Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1156-1164

  Chang, Kyong Mi ^a   Gruener, Norbert H ^b   Southwood, Scott ^c   Sidney, John ^c   Pape, Gerd R ^b   Chisari, Francis V ^a   Sette, Alessandro ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Epimmune   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B ANTIGEN;

ACUTE DISEASE; ALLELE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CHRONIC DISEASE; CROSS REACTION; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PEPTIDE SYNTHESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TARGET CELL;

ACUTE DISEASE; ADULT; ALLELES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HLA-A3 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033555410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Marcs, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, E. L. Meeks, and M. J. Beach. 1992. The natural history of community-acquired hepatitis C in the United States: The Sentinel Counties Chronic Non-A Hepatitis Study Team. N. Engl. J. Med 327:1899.
2. Battegay, M., J. Fikes, A. M. Di Bisceglie, P. A. Wentworth, A. Sette, E. Celis, W.-M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded pcptides binding to HLA-A2.1 molecules. J. Virol. 69:2462.
3. Botarelli, P., M. R. Brunette, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q.-L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, and S. Abrignani. 1993. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580.
4. Cerny, A., J. G. McHutchison, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grahscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521.
5. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M.-C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006.
6. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Guiberti, C. Schianchi, G. Missale, M. G. Marin, and F. Fiaccadori. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286.
7. + T lymphocyte epitopes of hepatitis C virus and their relevance during the course of chronic infection. Hepatology 21:632.
8. Houghton, M., A Weiner, J. Han, G. Kuo, and Q.-L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381.
9. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocyte specific for hepatitis C virus in persons with chronie hepatitis. J. Immunol. 149:3339.
10. Koziel, M. J., D. Dudley, N. Afdhal, Q.-L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522.
11. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q.-L. Choo, M. Houghton, and B. D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311.
12. Rehermann, B., K.-M. Chang, J. G. McHutchison, R. Kokka, M. Houghton, C. M. Rice, and F. V. Chisari. 1996. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092.
13. Rehermann, B., K.-M. Chang, J. G. McHutchison, R. Kokka, M. Houghton, and F. V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432.
14. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H.-J. Schlicht, A. Vitiello, R. Chesnut, J. L. Person, A. G. Redeker, and F. V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection, J. Immunol. 150:4659.
15. Rehermann, B., P. Fowler, J. Sidney, I. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047.
16. Bertoletti, A., F. V. Chisari, A. Penna, S. Guilhot, L. Galati, G. Missale, P. Fowler, H.-I. Schlicht, A. Vitiello, R. C. Chesnut, F. Fiaccadori, and C. Ferrari. 1993. Definition of a minimal optimal cytotoxic T cell epilope within the hepatitis B virus nucleocapsid protein. J. Virol. 67:2376.
17. Hiroishi, K., H. Kita, M. Kojima, H. Okamoto, T. Moriyama, T. Kaneko, T. Ishikawa, S. Obnishi, T. Aikawa, N. Tanaka, Y. Yazaki, K. Mitamura, and M. Imawari. 1997. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705.
18. Chang, K.-M., B. Rehermann, J. G. McHutchison, C. Pasquinelli, S. Southwood, A. Sette, and F. V. Chisari. 1997. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin. Invest. 100:2376.
19. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755.
20. Sidney, J., S. Southwood, M. F. del Guercio, H. M. Grey, R. W. Chesnut, R. T. Kubo, and A. Sette. 1996. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:3480.
21. Sidney, J., H. M. Grey, S. Southwood, E. Celis, P. A. Wentworth, M. F. del Guercio, R. T. Kubo, R. W. Chesnut, and A. Sette. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:79.
22. Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503.
23. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97.
24. Sette, A., J. Sidney, M.-F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813.
25. Guilhot, S., P. Fowler, G. Portillo, R. F. Margolskee, C. Ferrari, A. Bertoletti, and F. V. Chisari. 1992. Hepatitis B virus (HBV)-specific cytotoxic T cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J. Virol. 66:2670.
26. Committee, T. C. D. A. 1991. Allele frequencies. In The Data Book of the 11th International Histocompatibility Workshop. Vol. 2, Yokohama, Oxford University Press, New York, p. 807.
27. Fernandez-Vina, M. A., M. Falco, Y. Sun, and P. Stastny. 1992. DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of -A28. Hum. Immunol 33:163.
28. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. [See comments.] Nat. Med. 3:205.
29. Autran, B., F. Hadida, and G. Haas. 1996 Evolution and plasticity of CTL responses against HIV. Curr. Opin. Immunol. 8:546.
30. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
31. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.
32. Jager, E., M. Ringhoffer, H. P. Dienes, M. Arand, J. Karbach, D. Jager, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 67:54.
33. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet. et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 63:883 (Letter).
34. Nelson, E. L., X. Li, F. J. Hsu, L. W. Kwak, R. Levy, C. Clayberger, and A. M. Krensky. 1996. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood 88:580.
35. Hsu, F. J., C. B. Caspar, D. Czerwinski, L. W. Kwak, T. M. Liles. A. Syrengelas, B. Taidi-Laskowski, and R. Levy. 1997. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma: long-term results of a clinical trial. Blood 89:3129.
36. Livingston, B. D., C. Crimi, H. Grey, G. Ishioka, F. V. Chisari, J. Fikes, R. Chesnut, and A. S. Sette. 1997. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1383.
37. Kast, W. M., R. M. Brandt, J. Sidney, J. W. Drijfhout, R. T. Kubo, H. M. Grey. C. J. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904.
38. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
39. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478.
40. Nelson, D. R., C. G. Marousis, G. L. Davis, C. M. Rice, J. Wong, M. Houghton, and J. Y. N. Lau. 1997. The role of hepatitis C virus-specific cylotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:1473.